Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01792024 · ClinicalTrials.gov registry record · NA
MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer
A NA study of Stage I Prostate Cancer and Stage II Prostate Carcinoma, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT01792024: Completed NA study of Stage I Prostate Cancer and Stage II Prostate Carcinoma, sponsored by University of Chicago.
NCT01792024 is a NA study of Stage I Prostate Cancer and Stage II Prostate Carcinoma that has completed, run by University of Chicago. The registered enrollment target is 27 participants, below the 57-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01792024, a NA study of Stage I Prostate Cancer and Stage II Prostate Carcinoma, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase II trial studies how well magnetic resonance (MR)-guided laser interstitial thermal therapy works in treating patients with prostate cancer. Laser therapy uses intense, narrow beams of light to cut and destroy tissue and may help treat prostate cancer
Primary Outcome
The primary study end point was the number of patients with no cancer on MRI guided biopsy of the ablation zone at 3 months.
Conditions Studied
Interventions
- PROCEDURE magnetic resonance imaging
- DEVICE Visualase Thermal Therapy
Study Locations (1)
Illinois
- University of Chicago Comprehensive Cancer Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2013-01-28 |
| Est. Completion | 2015-09-16 |
| Phase | NA |
What the finished NCT01792024 record still lists
NCT01792024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 57-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target (53% lower).
The record links to 2 conditions, with Stage I Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which magnetic resonance imaging is the first listed.
NCT01792024 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01792024 about?
NCT01792024 is a clinical study titled "MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer". This phase II trial studies how well magnetic resonance (MR)-guided laser interstitial thermal therapy works in treating patients with prostate cancer. Laser therapy uses intense, narrow beams of light to cut and destroy tissue and may help treat prostate cancer
What is the current status of trial NCT01792024?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2013-01-28. Estimated completion is 2015-09-16.
What conditions does trial NCT01792024 study?
This clinical trial studies the following conditions: Stage I Prostate Cancer, Stage II Prostate Carcinoma.
What interventions are being tested in trial NCT01792024?
The interventions under investigation include: magnetic resonance imaging (PROCEDURE), Visualase Thermal Therapy (DEVICE).
Who is sponsoring clinical trial NCT01792024?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01792024 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage I Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01792024's enrollment target sits among peer trials
27 8th of 9 higher than 2 of 9 other Stage I Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stage I Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
RECRUITING · NA
-
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Researching the Effect of Exercise on Cancer
ACTIVE NOT RECRUITING · NA
-
Visually Enhanced Education About Prostate Cancer
COMPLETED · NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI